Cryotherapy versus salicylic acid for the treatment of verrucae: a randomised controlled trial. - EVerT

Phase 1

• Conditions: Verrucae

• Registration Number: EUCTR2004-000905-24-GB
• Lead Sponsor: niversity of York

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-02-15
• Study Completion: 2010-06-30
• Last Update Posted: 25 November 2019

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 266

Inclusion Criteria

Patients will be eligible to take part in the trial if the podiatrist confirms that they have a verruca that is suitable for treatment with either salicylic acid or cryotherapy.
Patients who are able and willing to give informed consent.

Clarification that patients should be eligible for 'both' forms of treatment. (Protocol version 5 4/5/2007)
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients will be ineligible to take part in the trial if they have impaired healing eg due to diabetes, peripheral vascular disease or any other condition which means the patient has impaired healing, if they are participating in another trial for the treatment of verrucae, or if they are unable to give informed consent.
Patients under the age of 12 will be excluded since cryotherapy may be an inappropriate form of treatment for that age group.

The following additional criteria have been included:
Patients currently taking immunosuppressant drugs such as oral corticosteroids (Protocol 3 26/7/06)

Patients on renal dialysis; have cold intolerance eg Raynaud's syndrome or cold urticaria; have any of the following conditions - blood dyscrasias of unknown origin, cryoglobulinaemia, cryofibrinogenaemia, collagen and auto-immune disease; patients that are immunosuppressed eg have agammaglobulinaemia (Protocol v 4 21/11/06)

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified